I'm not saying it has no value, I'm saying that their PR is wildly out of control and it's reflecting on the poor state of journalism more than the efficacy of the drug.
Here is a scathing review of it and the PR engine behind it from the NYT just a month ago, ironically: http://www.nytimes.com/2016/08/09/opinion/cancer-drug-ads-vs...
OPDIVO is another name for nivolumab.
No one should call a cancer treatment drug a 'game changer' unless it literally cures cancer in something like 90% of cases. Otherwise it's spreading false hope and it is actually immoral - if you consider that nearly everybody has been affected by cancer either directly or indirectly.